SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001702
Filing Date
2023-08-10
Accepted
2023-08-10 16:45:50
Documents
87
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q derm-20230630x10q.htm   iXBRL 10-Q 2019379
2 EX-10.1 derm-20230630xex10d1.htm EX-10.1 371431
3 EX-31.1 derm-20230630xex31d1.htm EX-31.1 12828
4 EX-31.2 derm-20230630xex31d2.htm EX-31.2 12745
5 EX-32.1 derm-20230630xex32d1.htm EX-32.1 6381
6 EX-32.2 derm-20230630xex32d2.htm EX-32.2 6327
  Complete submission text file 0001410578-23-001702.txt   8568960

Data Files

Seq Description Document Type Size
7 EX-101.SCH derm-20230630.xsd EX-101.SCH 63343
8 EX-101.CAL derm-20230630_cal.xml EX-101.CAL 67009
9 EX-101.DEF derm-20230630_def.xml EX-101.DEF 251249
10 EX-101.LAB derm-20230630_lab.xml EX-101.LAB 530487
11 EX-101.PRE derm-20230630_pre.xml EX-101.PRE 401459
81 EXTRACTED XBRL INSTANCE DOCUMENT derm-20230630x10q_htm.xml XML 1350161
Mailing Address 9237 E VIA DE VENTURA BLVD., SUITE 105 SCOTTSDALE AZ 85258
Business Address 9237 E VIA DE VENTURA BLVD., SUITE 105 SCOTTSDALE AZ 85258 480-434-6670
Journey Medical Corp (Filer) CIK: 0001867066 (see all company filings)

IRS No.: 471879539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41063 | Film No.: 231160297
SIC: 2834 Pharmaceutical Preparations